Telix Pharmaceuticals Limited (TLX) Ownership
TLX ownership summary
as of October 18, 2026- Institutions
- 1.0% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 339.8M
- Float
- 273.6M shares available to trade
- Short interest
- 0.14% 427K shares short
- Days to cover
- 0.92 short interest up 21.1% vs prior month
- Institutions 1.02%
- Other investors 98.98%
TLX top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | FMR Inc | 0.17% | 561K | $6.0M | −3,551 (−0.6%) | June 30, 2026 |
| 2 | Lazard Asset Management LLC | 0.08% | 284K | $3.0M | −5,710 (−2.0%) | June 30, 2026 |
| 3 | Manulife AIC Funds | 0.08% | 266K | $2.8M | — | June 30, 2026 |
| 4 | Private Advisor Group, LLC | 0.06% | 197K | $2.1M | +22,835 (+13.1%) | June 30, 2026 |
| 5 | Marshall Wace Asset Management Ltd | 0.06% | 189K | $2.0M | +189,188 (0.0%) | June 30, 2026 |
| 6 | Morgan Stanley - Brokerage Accounts | 0.05% | 166K | $1.8M | +49,538 (+42.5%) | June 30, 2026 |
| 7 | Integrated Wealth Concepts LLC | 0.05% | 164K | $1.8M | — | June 30, 2026 |
| 8 | Hennion & Walsh Asset Management Inc | 0.04% | 150K | $1.6M | +150,138 (0.0%) | June 30, 2026 |
| 9 | UBS Group AG | 0.04% | 135K | $1.4M | +102,398 (+317.0%) | June 30, 2026 |
| 10 | Blair William & Co | 0.04% | 123K | $1.3M | +122,985 (0.0%) | June 30, 2026 |
| 11 | Raiffeisen Bank International AG | 0.03% | 115K | $1.2M | −15,000 (−11.5%) | June 30, 2026 |
| 12 | Quadrature Capital Limited | 0.03% | 102K | $1.1M | +102,425 (0.0%) | June 30, 2026 |
| 13 | JPMorgan Chase & Co | 0.02% | 78K | $828,881 | +20,190 (+35.2%) | June 30, 2026 |
| 14 | XY Capital Ltd | 0.02% | 71K | $762,101 | +58,739 (+468.0%) | June 30, 2026 |
| 15 | XTX Topco Ltd | 0.02% | 69K | $735,215 | +42,769 (+164.5%) | June 30, 2026 |
| 16 | JustInvest LLC | 0.02% | 59K | $630,592 | +25,736 (+77.4%) | June 30, 2026 |
| 17 | NLB Skladi, upravljanje premozenja, d.o.o. | 0.02% | 58K | $620,020 | +58,000 (0.0%) | June 30, 2026 |
| 18 | Mariner Wealth Advisors LLC | 0.01% | 37K | $396,439 | −6,361 (−14.6%) | June 30, 2026 |
| 19 | Capricorn Fund Managers Ltd | 0.01% | 36K | $385,909 | +36,100 (0.0%) | June 30, 2026 |
| 20 | Jane Street Group LLC | 0.01% | 33K | $356,928 | +33,389 (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 14 holders added 1.0M shares and 4 cut 31K.
TLX top mutual fund and ETF holders
9 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Raiffeisen-Health&Wellbeing-ESG Akt A | 0.03% | 100K | $1.1M | — | August 31, 2026 |
| 2 | SVS Aubrey Global Conviction | 0.01% | 32K | $346,356 | +32,400 (0.0%) | August 31, 2026 |
| 3 | Selectra J Lamarck Pharma A | <0.01% | 14K | $149,660 | — | September 30, 2026 |
| 4 | ActivePassive International Equity ETF | <0.01% | 12K | $125,404 | — | September 30, 2026 |
| 5 | River Oak Discovery | <0.01% | 11K | $118,381 | +6,074 (+121.5%) | September 30, 2026 |
| 6 | Lazard Digital Health J Acc USD | <0.01% | 9,177 | $98,102 | — | June 30, 2026 |
| 7 | Fidelity Nasdaq Composite Index | <0.01% | 4,694 | $50,179 | −2,699 (−36.5%) | August 31, 2026 |
| 8 | Steward Values Enhanced International I | <0.01% | 3,943 | $42,151 | — | August 31, 2026 |
| 9 | Dimensional Glbl ex US CorEqMktETFUSDAcc | 0.00% | 57 | $609 | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
TLX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns TLX
Institutional investors own 1.0% of Telix Pharmaceuticals's shares and insiders 0.00%. The largest holder is FMR Inc with 0.17% of the shares (561K), as of June 30, 2026. Among the top 20 institutions, 14 added shares and 4 reduced their stake in the latest filings. Short interest is 0.14% of the float, or 0.92 days of average trading volume. The share count rose 26,702.1% since 2014.
Related: TLX analyst forecast, TLX key metrics. See the TLX stock overview for the latest quote and news.
TLX ownership FAQ
Who owns the most Telix Pharmaceuticals stock?
The largest shareholders of Telix Pharmaceuticals are FMR Inc (0.17%), Lazard Asset Management LLC (0.08%), Manulife AIC Funds (0.08%), Private Advisor Group, LLC (0.06%), Marshall Wace Asset Management Ltd (0.06%).
What percentage of Telix Pharmaceuticals is owned by institutions?
Institutions hold 1.0% of Telix Pharmaceuticals's shares outstanding; insiders hold 0.00%.
Which funds own Telix Pharmaceuticals?
The largest fund holders of Telix Pharmaceuticals are Raiffeisen-Health&Wellbeing-ESG Akt A (0.03%), SVS Aubrey Global Conviction (0.01%), Selectra J Lamarck Pharma A (<0.01%), ActivePassive International Equity ETF (<0.01%), River Oak Discovery (<0.01%).
What is Telix Pharmaceuticals's short interest?
427K shares of Telix Pharmaceuticals were sold short, 0.14% of the float; at the average daily volume it would take 0.92 days to cover.
How many shares of Telix Pharmaceuticals are outstanding?
Telix Pharmaceuticals has 339.8M shares outstanding, of which 273.6M are in the public float.